Bulletin
Investor Alert

Clovis Oncology Inc.

NAS: CLVS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201295534/composite

$

7.00

Change

+0.04 +0.50%

Volume

Volume 161,726

Sep 18, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201295534/composite

Previous close

$ 7.48

$ 6.97

Change

-0.52 -6.89%

Day low

Day high

$6.73

$7.52

Open
Open: 7.50

52 week low

52 week high

$2.93

$17.37

Open

Market cap

$614.33M

Average volume

5.02M

P/E ratio

N/A

Rev. per Employee

$203,821

EPS

-6.07

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/clvs

MarketWatch News on CLVS

  1. Clovis Oncology downgraded to underperform from market perform at SVB Leerink

    6:25 a.m. April 27, 2020

    - Tomi Kilgore

  2. Clovis Oncology stock price target cut to $5 from $10 at SVB Leerink

    6:26 a.m. April 27, 2020

    - Tomi Kilgore

  3. Pfizer’s New Strategy Makes It Worth Another Look

    3:52 p.m. Dec. 4, 2019

    - Barron's Online

  4. Clovis Oncology stock price target cut to $8 from $12 at Evercore ISI

    8:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  5. Clovis Oncology downgraded to in line from outperform at Evercore ISI

    8:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  6. The Dow Is Up Because There’s a Little More Hope About Trade

    9:16 a.m. Sept. 24, 2019

    - Barron's Online

  7. Clovis Oncology Falls After Analyst Blasts New Licensing Deal

    9:02 a.m. Sept. 24, 2019

    - Barron's Online

  8. Clovis Oncology downgraded to market perform from outperform at SVB Leerink

    8:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  9. Clovis Oncology stock price target cut to $10 from $21 at SVB Leerink

    8:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  10. Clovis Oncology stock price target cut to $22 from $40 at SVB Leerink

    8:27 a.m. Aug. 2, 2019

    - Tomi Kilgore

  11. The Dow is tumbling as recession fears meet the trade war

    11:56 a.m. May 29, 2019

    - Barron's Online

  12. Clovis Oncology Shares Drop on Cancer Drug Potential

    10:08 a.m. May 29, 2019

    - Barron's Online

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/clvs

Other News on CLVS

  1. Cancer advances ignite broad biotech and specialized ETF surge

    4:12 p.m. Sept. 15, 2020

    - Seeking Alpha

  2. Seeking Alpha Catalyst Watch

    3:30 p.m. Sept. 11, 2020

    - Seeking Alpha

  3. Clovis Oncology (CLVS) Gets a Buy Rating from H.C. Wainwright

    10:25 a.m. Sept. 9, 2020

    - SmarterAnalyst

  4. FDA OKs Roche pan-tumor liquid biopsy test

    6:30 a.m. Aug. 28, 2020

    - Seeking Alpha

  5. ABT, CLVS among premarket gainers

    8:21 a.m. Aug. 27, 2020

    - Seeking Alpha

  6. Clovis Oncology (CLVS) Receives a Hold from J.P. Morgan

    5:21 a.m. Aug. 21, 2020

    - SmarterAnalyst

  7. Clovis up 20% on rucaparib data in prostate cancer

    2:23 p.m. Aug. 17, 2020

    - Seeking Alpha

  8. Clovis (CLVS) Upgraded to Buy: Here's Why

    12:00 p.m. July 21, 2020

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/clvs

Press Releases on CLVS

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.